Results     01-Jun-18
Announcements
Marksans Pharma reports standalone net profit of Rs 4.33 crore in the March 2018 quarter
Sales rise 60.96% to Rs 86.84 crore
Net profit of Marksans Pharma reported to Rs 4.33 crore in the quarter ended March 2018 as against net loss of Rs 2.44 crore during the previous quarter ended March 2017. Sales rose 60.96% to Rs 86.84 crore in the quarter ended March 2018 as against Rs 53.95 crore during the previous quarter ended March 2017.

For the full year,net profit rose 7.62% to Rs 12.43 crore in the year ended March 2018 as against Rs 11.55 crore during the previous year ended March 2017. Sales rose 36.52% to Rs 294.66 crore in the year ended March 2018 as against Rs 215.84 crore during the previous year ended March 2017.

ParticularsQuarter EndedYear Ended
 Mar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.
Sales86.8453.95 61 294.66215.84 37
OPM %12.371.39 -12.3711.35 -
PBDT8.23-1.12 LP 28.9026.95 7
PBT5.69-4.94 LP 16.6511.95 39
NP4.33-2.44 LP 12.4311.55 8

Previous News
  Marksans Pharma gains after Q2 PAT rises 16% YoY to Rs 97 cr
 ( Hot Pursuit - 12-Nov-24   13:22 )
  Marksans Pharma rises after subsidiary gets EIR for New York-based facility from US FDA
 ( Hot Pursuit - 30-Jun-25   12:58 )
  Marksans Pharma to table results
 ( Corporate News - 22-Jan-25   14:06 )
  Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules
 ( Corporate News - 21-Aug-24   20:00 )
  Marksans Pharma consolidated net profit rises 29.26% in the June 2024 quarter
 ( Results - Announcements 14-Aug-24   07:54 )
  Marksans Pharma fixes record date for dividend
 ( Market Beat - Reports 24-May-23   17:38 )
  Board of Marksans Pharma recommends final dividend
 ( Corporate News - 20-May-25   12:49 )
  Marksans Pharma gains after arm gets nod for Baclofen tablets from UK MHRA
 ( Hot Pursuit - 19-Mar-25   12:50 )
  Time-Cap Laboratories successfully concludes USFDA inspection
 ( Corporate News - 30-Jun-25   12:56 )
  Marksans Pharma consolidated net profit rises 191.46% in the March 2023 quarter
 ( Results - Announcements 31-May-23   07:44 )
  Marksans Pharma spurts on buying Tevapharm's bulk formulations biz
 ( Hot Pursuit - 12-Oct-22   09:36 )
Other Stories
  MIC Electronics consolidated net profit declines 15.23% in the June 2025 quarter
  04-Jul-25   13:06
  Vasudhagama Enterprises consolidated net profit declines 86.67% in the March 2025 quarter
  30-Jun-25   07:28
  Mahesh Developers reports standalone net profit of Rs 0.05 crore in the March 2025 quarter
  28-Jun-25   07:32
  Maxgrow India reports standalone net loss of Rs 4.52 crore in the March 2025 quarter
  28-Jun-25   07:32
  Rose Merc. reports consolidated net loss of Rs 0.69 crore in the March 2025 quarter
  28-Jun-25   07:32
  NMS Global reports consolidated net profit of Rs 0.21 crore in the March 2025 quarter
  28-Jun-25   07:31
  GCCL Construction & Realities standalone net profit declines 46.67% in the March 2025 quarter
  27-Jun-25   07:34
  Konkan Railway Corporation standalone net profit declines 69.17% in the March 2025 quarter
  27-Jun-25   07:34
  Jorabat Shillong Expressway reports standalone net loss of Rs 10.15 crore in the March 2025 quarter
  27-Jun-25   07:34
  Rare Asset Reconstruction reports standalone net loss of Rs 2.46 crore in the March 2025 quarter
  27-Jun-25   07:34
Back Top